BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.
BSC® Solutions
VOICES
Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

Insights
What is a DSMB?

Insights
What is a DSMB?

Insights
What is a DSMB?
•
•
2 min read time
What is a DSMB?
A Data Safety Monitoring Board (DSMB), also known as a Data Monitoring Committee (DMC) or Independent Data Monitoring Committee (IDMC), is an independent group of experts responsible for monitoring the safety and efficacy of a clinical trial while it is ongoing. The primary role of the DSMB is to ensure the well-being of study participants and to maintain the scientific integrity of the trial.
Essential functions and responsibilities of a Data Safety Monitoring Board
Safety Monitoring: The DSMB regularly reviews safety data from the clinical trial to identify potential safety concerns or adverse events that may be related to the study intervention. Their primary focus is on the safety of trial participants.
Interim Analysis: The DSMB conducts pre-planned interim analyses of the accumulating trial data at specific time points or after a certain number of participants have completed the study. These analyses assess whether the study should continue as planned or if there are compelling reasons to modify or terminate the trial early.
Treatment Efficacy and Futility: Besides safety, the DSMB evaluates the treatment efficacy and overall trial progress. They may assess whether the treatment shows significant efficacy or whether the study is unlikely to achieve its primary objective (futility analysis).
Unblinding and Decision Making: The DSMB can access unblinded data to conduct its analyses. However, if pre-specified stopping boundaries are met, they keep the results confidential and only communicate relevant findings to the trial’s investigators or sponsors.
Recommendations: Based on their analyses, the DSMB may provide recommendations to the trial’s steering committee or sponsors. These recommendations can include modifications to the study protocol, changes to the sample size, early termination, or continuation of the trial as planned.
Independence: The DSMB must be independent of the investigators, sponsors, and study team to ensure an unbiased evaluation of the trial data. Their independence helps maintain the integrity and objectivity of the monitoring process.
Expertise: The DSMB comprises experts in relevant fields, such as clinical medicine, radiology, biostatistics, and ethics, who must have the expertise to evaluate the trial data effectively and efficiently.
DSMB activities are important
Establishing a Data Safety Monitoring Board is especially important for significant, long-term clinical trials involving vulnerable populations or high-risk interventions. It helps protect the welfare of study participants, ensures that the trial is conducted ethically, and enhances the credibility and validity of the study’s results. The DSMB’s role is to objectively assess the accumulating data and make informed recommendations to ensure the trial’s success and safety.
Contact us to support your DSMB trial efforts
Biomedical Statistical Consulting routinely advises and provides blinded and unblinded DSMB roles, including developing DSMB reports. Contact us to learn more.

BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

BSC®
Get regulatory insights
that help you work smarter.
Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Featured Resources
Get regulatory insights
from BSC®
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Request Expert Review
Backed by Regulatory Experience.
Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.
Confidential discussion with senior biostatisticians experienced in FDA submissions.
Use your preferred LLM to explore BSC®
Use your preferred LLM to explore BSC®


